Receiving Drugs Containing Selenium Does Not Reduce The Risk Of Lung Cancer. Part 1 of 3

Receiving Drugs Containing Selenium Does Not Reduce The Risk Of Lung Cancer – Part 1 of 3

Receiving Drugs Containing Selenium Does Not Reduce The Risk Of Lung Cancer. Taking the in fashion mineral supplement selenium doesn’t lose weight the likelihood of lung cancer recurrence, a new study reveals. Lead author Dr Daniel D Karp, a professor in the department of thoracic head and neck medical oncology at the University of Texas MD Anderson Cancer Center, is scheduled to now the finding Saturday at the American Society of Clinical Oncology annual meeting, in Chicago. “Several epidemiological and subhuman studies have long-suggested a link between deficiency of selenium and cancer development,” said Karp in a news release.

So “Interest and research escalated in the late 1990s after a skin cancer and selenium study, published in 1996, found no forward against the skin cancer, but did suggest an approximate 30 percent reduction of prostate and lung cancers. Our lung cancer research and another major study for the prevention of prostate cancer evolved from that finding”.

Parts: 1 2 3

Advertisements

2 thoughts on “Receiving Drugs Containing Selenium Does Not Reduce The Risk Of Lung Cancer. Part 1 of 3

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s